| Style | Citing Format |
|---|---|
| MLA | Faghihi H, et al.. "Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation." AAPS PharmSciTech, vol. 20, no. 3, 2019, pp. -. |
| APA | Faghihi H, Najafabadi AR, Daman Z, Ghasemian E, Montazeri H, Vatanara A (2019). Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation. AAPS PharmSciTech, 20(3), -. |
| Chicago | Faghihi H, Najafabadi AR, Daman Z, Ghasemian E, Montazeri H, Vatanara A. "Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation." AAPS PharmSciTech 20, no. 3 (2019): -. |
| Harvard | Faghihi H et al. (2019) 'Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation', AAPS PharmSciTech, 20(3), pp. -. |
| Vancouver | Faghihi H, Najafabadi AR, Daman Z, Ghasemian E, Montazeri H, Vatanara A. Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation. AAPS PharmSciTech. 2019;20(3):-. |
| BibTex | @article{ author = {Faghihi H and Najafabadi AR and Daman Z and Ghasemian E and Montazeri H and Vatanara A}, title = {Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation}, journal = {AAPS PharmSciTech}, volume = {20}, number = {3}, pages = {-}, year = {2019} } |
| RIS | TY - JOUR AU - Faghihi H AU - Najafabadi AR AU - Daman Z AU - Ghasemian E AU - Montazeri H AU - Vatanara A TI - Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation JO - AAPS PharmSciTech VL - 20 IS - 3 SP - EP - PY - 2019 ER - |